Effects of genetic polymorphisms of the renin-angiotensin system in children with nephrotic syndrome

被引:14
|
作者
Tabel, Y
Berdeli, A
Mir, S
Serdaroglu, E
Yilmaz, E
机构
[1] Ege Univ, Sch Med, Dept Pediat Nephrol, TR-35100 Izmir, Turkey
[2] Ege Univ, Sch Med, Dept Pediat, Mol Med Lab, TR-35100 Izmir, Turkey
关键词
RAS; gene polymorphism; nephrotic syndrome; children;
D O I
10.3317/jraas.2005.020
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. The renin-angiotensin system (RAS) has been considered to be responsible for the pathogenesis or progression of many diseases which may or may not be related to kidney. Genetic polymorphisms of the various components of the RAS have been associated with differences in the clinical Course of several disease states in adults and children. Objectives. The purpose of our study was to investigate RAS gene polymorphisms in patients with steroid resistant primary focal segmental glomerulosclerosis (FSGS) and nephrotic syndrome responding to steroid therapy. Furthermore, we aimed to investigate whether there was an association between polymorphic alleles and responses to steroid therapy, the degree of renal dysfunction, and prevalence of end-stage renal disease (ESRD). Material and methods. One hundred and fifty-eight children with the diagnosis of nephrotic syndrome were recruited from the Nephrology unit in the Department of Paediatrics of Ege University. Forty-nine of them were classified as renal biopsy-proven FSGS and 102 patients were considered to have response to steroid treatment. Renal functional impairment was detected in 19 subjects with FSGS and end-stage renal insufficiency in 13 patients. The control group consisted of 287 healthy adult subjects. Angiotensin-converting enzyme (ACE), angiotensin 11 type 1 receptor (AT(1)R) and angiotensinogen (AGT) gene polymorphisms were determined by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) technique. Statistical significance was regarded as p < 0.05. Results. There were no statistically significant differences for the C allele of AT(1)R or the T allele of AGT genes between the children with nephrotic syndrome and control group, but on the other hand statistically significant differences were detected for D allele of ACE gene. There was no significant relationship detected between the D allele of ACE, the C allele of AT(1)R or the T allele of AGT genes and response to steroid therapy, extent of renal dysfunction and the progression to ESRD. However, there was a significant relationship between T allele of AGT gene and resistance to steroid treatment (OR; 4,837, 95% Cl; 1,723-13,577, p=0.01), renal dysfunction (OR; 3,189, 95% Cl; 0,999-10,182, p=0.041) and progression to ESRD (OR; 3,852, 95% Cl; 1,057-14,040, p=0.03). Conclusion. In this study, the angiotensino gene -235T allele was found to be related with steroid resistance, renal dysfunction and progression of ESRD in nephrotic syndrome.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 50 条
  • [31] Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives
    Bozkurt, O.
    Verschuren, W. M. M.
    Wijer, B. M. A. van Wieren-de
    Knol, M. J.
    de Boer, A.
    Grobbee, D. E.
    Geerlings, M. I.
    Heerdink, E. R.
    Klungel, O. H.
    JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (11) : 774 - 780
  • [32] Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives
    Ö Bozkurt
    W M M Verschuren
    B M A van Wieren-de Wijer
    M J Knol
    A de Boer
    D E Grobbee
    M I Geerlings
    E R Heerdink
    O H Klungel
    Journal of Human Hypertension, 2008, 22 : 774 - 780
  • [33] Renin-angiotensin gene polymorphism in children with uremia and essential hypertension
    Ferenc Papp
    Aaron L. Friedman
    Csaba Bereczki
    Ibolya Haszon
    Éva Kiss
    Emőke Endreffy
    Sándor Túri
    Pediatric Nephrology, 2003, 18 : 150 - 154
  • [34] Renin-angiotensin gene polymorphism in children with uremia and essential hypertension
    Papp, F
    Friedman, AL
    Bereczki, C
    Haszon, I
    Kiss, É
    Endreffy, E
    Túri, S
    PEDIATRIC NEPHROLOGY, 2003, 18 (02) : 150 - 154
  • [35] Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes
    Bozkurt, Ozlem
    de Boer, Anthonius
    Grobbee, Diederik E.
    Kroon, Abraham A.
    Schiffers, Paul
    de Leeuw, Peter
    Klungel, Olaf H.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2009, 10 (02) : 101 - 108
  • [36] Ascites fluid of nephrotic rats:: Sodium dodecyl sulphate polyacrylamide gel electrophoresis protein pattern and the renin-angiotensin system
    Cruz, C
    Correa-Rotter, R
    Mézquita, C
    Medina-Campos, ON
    Pedraza-Chaverrí, J
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (7-8) : 568 - 571
  • [37] Renin-angiotensin-system gene polymorphisms and depression
    Saab, Yolande B.
    Gard, Paul R.
    Yeoman, Mark S.
    Mfarrej, Bechara
    El-Moalem, Habib
    Ingram, Matthew J.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (05): : 1113 - 1118
  • [38] Renin-angiotensin system at the interface of COVID-19 infection
    Gul, Rukhsana
    Kim, Uh-Hyun
    Alfadda, Assim A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 890
  • [39] Association between polymorphisms of the renin-angiotensin system and coronary artery disease in Chinese patients with type 2 diabetes
    Lei, He-Ping
    Chen, Hong-Mei
    Zhong, Shi-Long
    Yao, Qing-Zhou
    Tan, Hong-Hong
    Yang, Min
    Lin, Qiu-Xiong
    Shan, Zhi-Xin
    Zheng, Zhi-Wei
    Zhu, Jie-Ning
    Zhou, Zhi-Ling
    Lin, Shu-Guang
    Yu, Xi-Yong
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2012, 13 (02) : 305 - 313
  • [40] Urinary Markers of Intrarenal Renin-Angiotensin System Activity In Vivo
    Roksnoer, Lodi C. W.
    Verdonk, Koen
    van den Meiracker, Anton H.
    Hoorn, Ewout J.
    Zietse, Robert
    Danser, A. H. Jan
    CURRENT HYPERTENSION REPORTS, 2013, 15 (02) : 81 - 88